
Sign up to save your podcasts
Or


Currently, mRNA-based vaccines are being developed for treating various diseases including cancers. https://mrna.creative-biolabs.com/technologies-platforms.htm
Researches show that this approach results in long-lasting clinical remission in cancer patients and protective immunity against infections. Here we make a brief introduction about two technologies widely used in mRNA research.https://mrna.creative-biolabs.com/technologies-platforms.htm
Increasing evidence revealed that mRNA molecules play a significant role in the progression of some diseases, which provides a new sight to use mRNA as a drug for the treatment of genetic diseases. https://mrna.creative-biolabs.com/technology.htm
The Tet-regulatory system has several advantages over other approaches used to measure mRNA half-life. The Tet-regulatory system provides the opportunity to study the regulation under physiologically relevant and undisturbed conditions and to investigate mechanisms underlying differential and selective mRNA turnover in mammalian cells.
A more recently developed Tet-off regulatory promoter system offers an alternate strategy that further broadens the application of the pulsing transcriptional approach to study mRNA turnover in mammalian cells. https://mrna.creative-biolabs.com/tet-off-regulatory-promoter-system.htm
Transient gene transfer aims at administering the mAb-encoding nucleotide sequences directly to patients. This allows the in situ production of biologicals in a labor- and cost-effective manner, potentially for a prolonged period of time. https://mrna.creative-biolabs.com/therapeutic-antibody-coding-mrna.htm
An elegant solution to circumvent the problems of complex production, purification processes and aberrant post-translational modifications of the monoclonal antibody (mAb), is to deliver the genetic information of the antibody itself. https://mrna.creative-biolabs.com/therapeutic-antibody-coding-mrna.htm
Nowadays, different approaches to turning messenger RNA (mRNA) into a potent therapeutic have been developed. All of them share utilization of specifically designed, instead of endogenous sequences and thorough purification protocols.https://mrna.creative-biolabs.com/therapeutic-antibody-coding-mrna.htm
Nowadays, different approaches to turning messenger RNA (mRNA) into a potent therapeutic have been developed. All of them share utilization of specifically designed, instead of endogenous sequences and thorough purification protocols.https://mrna.creative-biolabs.com/therapeutic-antibody-coding-mrna.htm
This product GTTS-WQ11MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & N1-Methylpseudo-UTP. It ecodes the monoclonal antibody that targets S gene. The antibody can be applied in Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (COVID-19) research. https://mrna.creative-biolabs.com/ivtscrip-mrna-anti-s-2130-cap-0-n1-methylpseudo-utp-120-nt-poly-a-21.htm
From the publisher's feed